American Transit Insurance Company v. Bilyk

CourtDistrict Court, E.D. New York
DecidedDecember 14, 2020
Docket1:19-cv-05171
StatusUnknown

This text of American Transit Insurance Company v. Bilyk (American Transit Insurance Company v. Bilyk) is published on Counsel Stack Legal Research, covering District Court, E.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
American Transit Insurance Company v. Bilyk, (E.D.N.Y. 2020).

Opinion

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK ----------------------------------------------------------- X AMERICAN TRANSIT INSURANCE : COMPANY, : MEMORANDUM : DECISION AND ORDER Plaintiff, : : 19-cv-5171(BMC) - against - : : YULIA BILYK, et al., : : : Defendants. : ----------------------------------------------------------- X COGAN, District Judge. Like all automotive accident insurance companies operating in New York, plaintiff American Transit Insurance Company (“ATIC”)attracts some fraudulent or exaggerated policy claims under New York’s no-fault insurance scheme. In response, ATIChas filed a RICO action against 29named individuals and companies andanother 40 John Doe individuals and companies, and has generally identified an unknown number of other entities not sued in this action, alleging that they constitute an “Enterprise” under RICO that has engaged in a pattern of racketeering activity. Many of the nameddefendants have settled, and those who haven’t settled have defaulted. ATICseeks a default judgment against those who have defaulted. When a complaint is 186 pages long,plus more than 300 pages of annexed exhibits, and contains 58 claims for relief, that is a red flag that something may be wrong with it. Federal Rule of Civil Procedure 8(a) requires a short and plain statement of the case, and even in cases that require compliance with Rule 9(b), as does this one, particularity is not the same as verbosity. Plaintiff has used surplusage to obscure the legal inadequacy of anyRICO claims here. ATIC itself identifies the problem when, early on in its complaint, it asserts that the claims it alleges consist of “separate but fundamentally similar schemes.” That is an understatement. In fact, the only “fundamental” similarity is that all the insurance claims upon which the complaint is based were either fictitious or overstated. But the schemes involved fraudulent claims of many

different types; and so,beyond the underlying criminality of the acts, plaintiff appearsto mistake genericism for proof of conspiracy. The complaint actually purports to allege fifteenseparate RICO schemes. Although the complaint alleges some defendants and unnamed coconspirators worked in teams of two, three or four to submit some number of these fraudulent insurance claims, there is no allegation that any of these groups worked with anothergroup. There are no allegations that these groups sharedthe proceeds from the fraudulent claims or evenhadany knowledge of each other. Even within each separate RICOscheme, there are no particulars as to which of the many fraudulent methods the particular scheme utilized. This is not merely the absence of a hierarchical structure; it is the

absence of any organization at all. What ATIC has done is simplytakendozens of separate actors who submitted claims that may have been fraudulent in a variety of unrelated ways and suedthem all in one action. A court cannot grant a default judgment on a complaint that fails to state a claim. The motion for a default judgment is therefore denied and the case is dismissed. SUMMARY OF COMPLAINT The complaint identifies threecategories of defendant –“Retail,” Wholesale,” and “No- Fault Clinics” –with each alleged enterprise generally comprised of one of every category. The complaint proceeds to explain how these three specialized types of defendants interacted as a single unit to submit fraudulent claims at plaintiff’s expense. The “Retail Defendants” consist of medical supply companies and the individual defendants who own them; the “Wholesale Defendants” consist of companies and their owners who sell medical supplies to the Retail Defendants; the “No-Fault Clinics,” which have not been sued in this action, provided or purported to provide medical services or devices to patients. It is not clear if any of the patients,

who are also not named, participated inthe schemes or were simply a means to accomplish the submission of fraudulent claims. The fraudulent claims began at the clinic level. A No-Fault Clinic health care provider would write a prescription for an automobile accident patient. Maybe this was a real accident patient; maybe it was a patient from a staged accident; maybe there was no patient at all, just the name of one who was insured. In any event, the prescription would be “fraudulent.” That might mean, depending on the provider or what the provider chose to do, that it was “fabricated,” or it might mean that the provider wrote the prescription “pursuant to a predetermined treatment protocol, regardless of medical necessity.” The complaint is not clear if some non-defendant No-

Fault Clinics would use one or the other of these fraudulent devices or both of them. The fraudulent prescriptions would be for one or more medical devices commonly needed by car accident victims. The complaint lists the following as such possible prescribed devices, “among other things”: cervical pillows, cervical traction units, cold/hot water circulating pumps, EMS units, infrared heat lamps, lumbar cushions, massagers, mattresses,andwhirlpools. The complaint refers to these and the “other things” as “durable medical equipment,” or DME. Or the fraudulent prescriptions might be for other items, “including without limitation, back braces, cervical collars, knee braces,and shoulder braces.” The complaint refers to these devices “without limitation” as “orthotic devices.” I am going to refer to all the DME and orthotic devices as “medical supplies,” but it bears noting that this covers a vast array of products, each of which may or may not compete in the wholesale or retail markets with similar products of different prices. The next step would be for the No-Fault Clinic to enter into an “arrangement” withboth a Retail Defendant and a Wholesale Defendant –although in some instances it might be only with

the Retail Defendant, who then might enter into a separate arrangement with a Wholesale Defendant either as to a particular claim or perhaps for a group of claims that may or may not relate to claims filed by other No Fault Clinics. I am going to refer to each of these combinations of Clinic, Retail Defendant, and Wholesale Defendant as a “Team.” There are no uniform terms of each Team’s “arrangements,” but one way the scheme would occur is that a patient would receive a prescription foran “item of DME and/or orthotic device .. . pursuant to a predetermined course of treatment, irrespective of medical necessity, based on illicit kickback and/or other financial compensation agreements.” Then, the Retail Defendant would put in an insurance claim and plaintiff would pay the Retail Defendant, with

the proceeds split in ways that are not alleged. Many of these schemes were dependent on the patients assigning their no-fault benefits to the No-Fault Clinic that treated themso that the No-Fault Clinic could submit the insurance claim. For example, in some cases, aTeam would have a patient sign receipts acknowledging that he had received the medical equipment, even though hehad not and never did. But in other cases, a Clinic patientactually received a device, and may indeed have benefited medically from it, although it might be a cheap device thata Wholesale Defendant hadfraudulentlyinvoiced as an expensive device. The complaint further alleges that,for each fraudulent claim, the prescriptions were “generic.” This enabled each Team to obscure whether the most or least expensive medical device was needed or provided, while allowing the claim to reflect the most expensive piece of medical equipment that could be covered by the generic description. The generic prescription also made it impractical or impossible for plaintiff to trace precisely the device that any patient

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United Mine Workers of America v. Gibbs
383 U.S. 715 (Supreme Court, 1966)
Sedima, S. P. R. L. v. Imrex Co.
473 U.S. 479 (Supreme Court, 1985)
Spool v. World Child International Adoption Agency
520 F.3d 178 (Second Circuit, 2008)
In Re Blech Securities Litigation
928 F. Supp. 1279 (S.D. New York, 1996)
Moll v. US Life Title Ins. Co. of New York
654 F. Supp. 1012 (S.D. New York, 1987)
Cedar Swamp Holdings, Inc. v. Zaman
487 F. Supp. 2d 444 (S.D. New York, 2007)
Rolls-Royce PLC v. Rolls-Royce USA, Inc.
688 F. Supp. 2d 150 (E.D. New York, 2010)
Goldfine v. Sichenzia
118 F. Supp. 2d 392 (S.D. New York, 2000)
RxUSA Wholesale, Inc. v. ALCON LABORATORIES, INC.
661 F. Supp. 2d 218 (E.D. New York, 2009)
Ho Myung Moolsan Co. v. Manitou Mineral Water, Inc.
665 F. Supp. 2d 239 (S.D. New York, 2009)
Gunawan v. Sake Sushi Restaurant
897 F. Supp. 2d 76 (E.D. New York, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
American Transit Insurance Company v. Bilyk, Counsel Stack Legal Research, https://law.counselstack.com/opinion/american-transit-insurance-company-v-bilyk-nyed-2020.